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Background: The aims of the study were: (1) to compare numerical parameters of specific 
airway resistance (total, sRawtot, effective, sRaweff and at 0.5 L ⋅ s-1, sRaw0.5) and indices obtained 
from the forced oscillation technique (FOT: resistance extrapolated at 0 Hz [Rrs0 Hz], mean 
resistance [Rrsmean], and resistance/frequency slope [Rrsslope]) and (2) to assess their relationships 
with dyspnea in chronic obstructive pulmonary disease (COPD).
Methods: A specific statistical approach, principal component analysis that also allows 
graphic representation of all correlations between functional parameters was used. A total of 
108 patients (mean ± SD age: 65 ± 9 years, 31 women; GOLD stages: I, 14; II, 47; III, 39 and 
IV , 8) underwent spirometry, body plethysmography, FOT, and Medical Research Council 
(MRC) scale assessments.
Results: Principal component analysis determined that the functional parameters were 
described by three independent dimensions (airway caliber, lung volumes and their combina-
tion, specific resistance) and that resistance parameters of the two techniques were not equiva-
lent, obviously. Correlative analyses further showed that Rawtot and Raweff (and their specific 
resistances) can be considered as equivalent and correlated with indices that are considered 
to explore peripheral airways (residual volume (RV), RV/ total lung capacity (TLC), Rrsslope), 
while Rrsmean and Raw0.5 explored more central airways. Only specific resistances taking into 
account the specific resistance loop area (sRawtot and sRaweff) and Rrsslope were statistically 
linked to dyspnea.
Conclusion: Parameters obtained from both body plethysmography and FOT can explore 
peripheral airways, and some of these parameters (sRawtot, sRaweff, and Rrsslope) are linked to 
activity-related dyspnea in moderate to severe COPD patients.
Keywords: body plethysmography, forced oscillation technique, principal component 
analysis
Introduction
DuBois and colleagues developed different ways of assessing airway obstruction in 
the late 1950s, namely airway resistance obtained from body plethysmography and 
respiratory system resistance from FOT.1,2 The former method seems neglected and 
is absent from the most recent international recommendations on pulmonary function 
testing, while the latter has regained interest and was the subject of recommendations 
by the European Respiratory Society (ERS) in 2003.3
The American Thoracic Society (ATS)/ERS Task Force stated that “airflow 
resistance is rarely used to identify airflow obstruction in clinical practice. It is more 
sensitive for detecting narrowing of extrathoracic or large central intrathoracic air-
ways than of more peripheral intrathoracic airways,”4 which may justify its disuse. 
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  Nevertheless, there are several lines of evidence indicating 
that airway resistance obtained from body plethysmography 
is less proximal than often stated. For instance, we have 
established that in asthmatic children, sRaw0.5 and Raw0.5 
(airway resistance at a flow of 0 ± 0.5 L/s) more closely 
correlated with forced expiratory flow (FEF)50% than with 
forced expiratory volume (FEV)1, both conceptually and 
empirically.5 We have also shown that in COPD patients, 
the best correlate of Raw (inspiratory Rawtot) was the lumen 
area of the sixth bronchial generation on the CT scan, which 
is not quite   proximal.6 Based on these assumptions, the 
clinical usefulness of airway resistance measurement in 
COPD patients deserves to be investigated together with 
the determination of which numerical parameters should 
be chosen.
Indeed, the different numerical parameters that can be 
calculated from the specific resistance loop further com-
plicate matters. The content of the sRaw loop is often quite 
complex and is not a simple narrow linear oval loop, espe-
cially in COPD patients. Consequently, different investigators 
have utilized different portions of the loop to approximate 
a representative value for the entire cycle. The total specific 
resistance (sRawtot), effective specific resistance (sRaweff), 
and the specific resistance at 0.5 L . s-1 (sRaw0.5) have been 
well established, which further allows the calculation of 
Rawtot, Raweff, and Raw0.5, respectively.1,7–10 As stated by Dab 
and Alexander in their initial description of specific resis-
tance measurement, sRaw “is a volume-corrected resistance 
which better describes an individual’s pulmonary function 
than the use of either Raw or Thoracic Gas Volume alone.”11 
Nevertheless, the comparison of sRaw and Raw numerical 
parameters in COPD patients is still lacking, to the best of 
our knowledge.
The resistive component of respiratory impedance, 
Rrs, includes proximal and distal airways, lung tissue, and 
chest wall resistance.3 In healthy subjects, Rrs is almost 
independent of oscillation frequency and mainly assesses 
airway resistance. In distal airway obstruction, Rrs is high-
est at low oscillation frequencies and falls with increasing 
frequency. As a consequence, it has been stated that FOT 
includes functional assessment of peripheral airways, which 
may explain the regain of interest in it.3 Overall, the analy-
sis of the relationships between all functional parameters 
obtained from spirometry, body plethysmography, and 
FOT in COPD patients would help to better define their 
functional redundancy and their respective contribution to 
activity-related dyspnea. Therefore, our first objective was 
to compare the different parameters characterizing resistance 
obtained from both whole-body plethysmography and FOT 
in COPD patients, while the second objective was to assess 
their clinical usefulness using correlative analyses with 
activity-related dyspnea. Since multiple parameters are 
obtained from pulmonary function tests, the first objective 
was achieved using a specific statistical approach, principal 
component analysis that also allows graphic representation 
of all correlations, allowing visualization of their similarities 
and differences.
Patients and methods
This was a cross-sectional study in which informed consent 
was obtained and ethical approval was received from an 
Institutional Review Board Committee (CPP IDF IV , n° 
1391593 v0). These results constitute an ancillary study 
of  a project designed for dyspnea assessment in patients 
with altered ventilatory capacity (DYSPNEE1 study, manu-
script submitted). Only data from COPD patients (smoking 
history .15 pack-years and post-bronchodilator FEV1/
forced vital capacity (FVC) , 70%)12 who underwent respi-
ratory system impedance (Oscilink; Datalink-MSR, Rungis, 
France), spirometry, and body plethysmography measure-
ments (MasterScreenBody, Jaeger, CareFusion, San Diego, 
CA) according to ATS/ERS recommendations,3,13–15 while 
receiving their regular COPD treatment, were included in 
the present analyses. Patients were not included if they had 
(1) other unstable medical conditions that could cause or 
contribute to breathlessness (ie, metabolic, cardiovascular, 
or other respiratory diseases), (2) pulmonary hypertension 
(systolic pulmonary artery pressure .35 mmHg at rest on 
echocardiography), or (3) a severe psychiatric condition.
Dyspnea during daily activities was assessed using the 
Medical Research Council (MRC) Scale.16
The different indices characterizing sRaw were:9,10 
sRawtot (parameter line connecting the flow points at 
maximum change in plethysmographic volume (pressure)), 
sRaw0.5 (parameter line connecting the points where the flow 
reaches a fixed value of 0.5 L/s), and sRaweff (calculated 
from multiple points throughout the breathing cycle: the 
integration method).3 From the FOT technique, the follow-
ing indices were obtained: the average resistance between 
4 and 30 Hz (Rrsmean, kPa ⋅ s-1 ⋅ L-1), the intercept (Rrs0 Hz, 
resistance extrapolated to 0 Hz: obtained by linear regression 
analysis over the 4 to 16 Hz frequency range), the resistance/
frequency slope (Rrsslope, between 4 and 16 Hz: null to nega-
tive values), and the compliance of the respiratory system 
(Cp, mL ⋅ hPa-1 using model fitting on the reactance data). All 
these parameters have previously been described extensively 
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and were standardized as percentages of predicted normal 
values.3,4,17–19
Statistical analyses
Since multiple parameters were obtained from pulmonary 
function tests, we first reduced the number of parameters to 
fewer relevant dimensions based on a statistical approach, 
namely principal component analysis (PCA). To obtain 
reliable results, we determined that the minimum number 
of subjects providing usable data for the analysis should be 
five times the number of variables being analyzed (n = 20).20 
This transformation is defined in such a way that the first 
principal component has a variance as high as possible and 
each succeeding component in turn has the highest variance 
possible under the constraint that it is orthogonal to (uncor-
related with) the preceding components. PCA is the simplest 
of the true eigenvector-based multivariate analyses. Its opera-
tion is often thought of as revealing the internal structure of 
the data in a way that best explains the variance in the data 
(see the legend of Figure 2 for additional explanation). We 
used the “cumulative percentage of variance accounted for” 
as the criterion for solving the problem with the number of 
components and retained enough components so that the 
cumulative percentage of variance accounted for at least 
∼70% (this was further confirmed via a Cattell scree plot: 
Figure 1). Correlative analyses between the MRC score and 
pulmonary function parameters used the Pearson coefficient. 
A P value ,0.05 was considered significant. The statistical 
software SAS (release 9.2; SAS Institute Inc, Cary, NC, 
USA) was used for all analyses.
Results
Patients
A total of 108 patients were enrolled into the study. The 
clinical and functional characteristics of the patients are 
described in Table 1. The initial sample size of the COPD 
group was 128, but four had lung volume measurement 
using helium dilution and FOT measures were lacking for 
16 additional patients.
Relationships between functional  
indices
Principal component analysis
The PCA allowed the description of all functional parameters 
according to the three axes responsible for 79.3% of total 
inertia. Figure 2 displays the functional indices in three dif-
ferent planes that help explain their respective relationships. 
The upper and middle panels show that axis 1 (responsible 
for the main part of inertia ∼variance) is well described by 
specific resistances (mixed parameter: airway obstruction and 
volume, analogous to viscosity according to its unit). Axis 2 
is probably related to lung volumes; among static volumes, 
TLC is closer to the axis than functional residual capacity 
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Figure 1 Percentage of inertia explained by the orthogonal axes obtained by principal component analysis. 
Note: The first axis is responsible for roughly half the inertia and there was a clear decrease in the explained inertia after the first three axes (Cattell scree plot).
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Figure 2 Correlation circles in two-dimensional maps.
Notes: The correlation circles show a projection of the initial variables in the factor 
space. Three planes are described according to the orthogonal dimensions determined 
by the PCA analysis. In a plane, when two variables are far from the center, then we 
can infer the following: if they are close to each other, they are significantly positively 
correlated (r close to 1); if they are orthogonal, they are not correlated (r close to 0); 
and if they are on opposite sides of the center, they are significantly negatively correlated 
(r close to -1). When the variables are close to the center, this means that some 
information is carried on other axes and that any interpretation would be hazardous.
Upper panel: representation of correlation circle in the first plane determined by 
axes 1 and 2. Middle panel: second plane determined by axes 1 and 3. Lower panel: 
third plane determined by axes 2 and 3. Since TLC was close to axis 2 (upper and 
lower panel), we may infer that this axis mainly represents lung volume.  As volume 
is linked to compliance, one may hypothesize that positive values of the axis are 
linked to compliance while negative values are linked to elastance. The eigenvectors 
of FOT indices (Rrs0 Hz and Rrsmean) are the closest to the third axis (positive values), 
which may mainly represent resistance of the respiratory system, while negative 
values on this axis could be linked to respiratory system conductance. Finally, the 
positive values of the first axis (main inertia) are described well by the specific airway 
resistance values (sRawtot and sRaweff) that have a viscosity unit (kPa ⋅ s).
Abbreviations: Rrs, resistance of the respiratory system (mean over 4–30 Hz; 0 Hz, 
resistance extrapolated to 0 Hz; slope, resistance/frequency slope); Ca, capacitance 
of the respiratory system obtained by FOT (~compliance); Raw, airway resistance 
(tot [total], eff [effective], 0.5 [at 0.5 L/s]) and their specific resistances (sRaw); TLC, 
total lung capacity; FRC, functional residual capacity; RV, residual volume; FEV1, forced 
expiratory flow at 1 s; FEF25%–75%, forced expiratory flow between 25% and 75% of 
vital capacity; FEF50%, forced expiratory flow at 50% vital capacity; FVC, forced vital 
capacity; IC, inspiratory capacity.
Table  1  Clinical  and  functional  characteristics  of  the  COPD 
patients
Characteristic 
Mean ± SD or n (%)
COPD 
N = 108
Age, years 65 ± 9
Sex ratio, F/M 31/77
Weight, kg 70 ± 14
Height, m 1.71 ± 0.08
BMI, kg ⋅ m-2 23.9 ± 4.0
Current smokers 44 (41%)
Ex-smokers 64 (59%)
Cigarettes, pack-years 52.5 ± 25.9
GOLD classes: I, II, III, IV 14/47/39/8
Scores:
MRC I/II/III/IV/V, n 34/37/23/8/6
Pulmonary function tests
Spirometry, slow vital capacity
  FEV1, L 1.58 ± 0.63
  FEV1, % predicted 56 ± 20
  FVC, L 2.79 ± 0.77
  FVC, % predicted 79 ± 19
  FEF25%–75%, L ⋅ s-1 0.75 ± 0.48
  FEF25%–75%, % predicted 24 ± 13
  IC, L 2.17 ± 0.65
  IC, % predicted 74 ± 19
Lung volume measurements
Plethysmography
  TLC, L 6.95 ± 1.41
  TLC, % predicted 111 ± 19
  FRC, L 4.78 ± 1.30
  FRC, % predicted 144 ± 36
  RV, L 3.84 ± 1.26
  RV, % predicted 165 ± 51
  RV/TLC 0.55 ± 0.11
  Raw0.5, kPa ⋅ s ⋅ L-1 0.28 ± 0.12
  sRaw0.5, kPa ⋅ s 1.49 ± 0.81
  Rawtot, kPa ⋅ s ⋅ L-1 0.48 ± 0.22
  sRawtot, kPa ⋅ s 2.66 ± 1.63
  Raweff, kPa ⋅ s ⋅ L-1 0.42 ± 0.19
  sRaweff, kPa ⋅ s 2.31 ± 1.40
  FEV1%pred/RV%pred 0.39 ± 0.24
Forced oscillation technique
  Rrs0 Hz, kPa ⋅ s ⋅ L-1 0.52 ± 0.20
  Rrs0 Hz, % predicted 208 ± 80
  Rrsmean, kPa ⋅ s ⋅ L-1 0.33 ± 0.10
  Rrsmean, % predicted 197 ± 76
  Rrsslope, kPa ⋅ s² ⋅ L-1 -0.0145 ± 0.0093
  Rrsslope, % predicted 3954 ± 36637
  Compliance, mL ⋅ hPa-1 17.84 ± 24.82
  Compliance, % predicted 83.13 ± 124.76
Abbreviations: F/M, female/male; BMI, body mass index; MRC, Medical Research 
Council dyspnea scale; Rrs, resistance of the respiratory system (mean over 4–30 
Hz; 0 Hz, resistance extrapolated to 0 Hz; slope, resistance/frequency slope) and 
their specific resistances (sRaw); Raw, airway resistance (tot [total], eff [effective], 
0.5 [at 0.5 L/s]); TLC, total lung capacity; FRC, functional residual capacity; RV, 
residual volume; FEV1, forced expiratory flow at 1 s; FEF25%–75%, forced expiratory 
flow between 25% and 75% of vital capacity; FEF50%, forced expiratory flow at 50% 
vital capacity; FVC, forced vital capacity; IC, inspiratory capacity.
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(FRC) and RV due to increasing contribution of obstruction 
to these latter volumes. This axis may be related to compli-
ance/elastance of the respiratory system. Finally, axis 3 is 
mainly related to airway caliber: increased resistance for 
positive values and hyperinflation for negative values, which 
is related to the resistance/conductance of the respiratory 
system. FEV1%pred/RV%pred was also computed because this 
new index may theoretically describe both airflow limitation 
and hyperinflation.
Figure 2 emphasizes the pathophysiological indication 
of the indices obtained from FOT in COPD; compliance is 
weakly described by the three axes that have been chosen. The 
Rrsslope (negative values) is in the opposite direction to Raw and 
is better described by the first axis, while Rrsmean and Rrs0 Hz 
are parameters of airway obstruction that are influenced by a 
decrease in lung volume (possibly due to airway closure).
Correlations between the functional parameters
Airway resistance
In our patients, Raweff and Rawtot (and their specific resis-
tances) can be regarded as equivalent (Pearson correlation 
coefficient, r = 0.96, P , 0.0001, and r = 0.98, P , 0.0001, 
respectively). Among the other functional indices (except 
resistances), the best correlates to Rawtot were FEV1 and 
RV/TLC (r = -0.63 and r = -0.62, respectively; both 
P   values , 0.0001), while the best correlates to sRawtot were 
RV and FEV1/FVC (r = 0.75 and r = -0.66, respectively; both 
P values , 0.0001).
Respiratory system resistance
All the functional indices (except other indices obtained 
from FOT measurement) weakly correlated with Rrsmean 
and Rrs0 Hz (r values , 0.50). The best correlates of the 
slope of the respiratory system resistance were Rawtot, 
Raweff, sRawtot, and sRaweff (all r values ∼ -0.60, all P 
values ,0.0001).
Relationships with activity-related dyspnea  
(MRC score)
All parameters that statistically correlated with the MRC 
score had a similar degree of explained variance (for instance, 
FEV1: r = -0.23 [-0.40; -0.04], P = 0.025). Among the resis-
tance measurements, the only indices that significantly cor-
related with the MRC score were sRawtot and sRaweff (r = 0.24 
[0.05; 0.41], P = 0.012 and r = 0.23 [0.04; 0.40], P = 0.017, 
respectively). The only parameter obtained from the FOT 
measurement that significantly correlated with the MRC 
score was Rrsslope (r = -0.25 [-0.42; -0.06], P = 0.010).
Discussion
The main result of this study is that all parameters characterizing 
resistance obtained from both whole-body plethysmography 
and FOT in COPD patients were not equivalent. The PCA 
analysis allows the visualization of their relationships. Our 
results demonstrated that Rawtot and Raweff (and their specific 
resistances) can be considered as equivalent and correlated 
with indices that are considered to explore peripheral airways 
(RV , RV/TLC, Rrsslope), while Rrsmean (and possibly Raw0.5) 
explored more central airways. We further showed that only 
specific resistances (sRawtot and sRaweff) and Rrsslope were sta-
tistically linked to activity-related dyspnea in COPD patients.
Methodological issues
First, the choice of the statistical analysis needs justification. 
When dealing with multiple parameters that are in essence 
correlated, it is difficult to obtain an overall view of their simi-
larities and differences. PCA allows this overall view, since it 
creates from all the parameters the independent dimensions 
that need further “physiological interpretation”: the three axes 
in our study, which may represent specific resistance, volume, 
and airway caliber. Each parameter is then characterized by 
a vector and its location in each plane may characterize its 
functional meaning. Correlative analyses between parameters 
are provided to further illustrate the strength of the relation-
ships, and two parameters can be considered as equivalent 
when the Pearson correlation coefficient is .0.85.
As stated by the ERS task force, since the first FOT 
measurements,2 numerous variants of the FOT have been 
developed in terms of measurement configuration, oscillation 
frequencies and evaluation principles.3 It has to be stated that 
some of the calculated parameters as Rrs0 Hz, Rrsslope and Cp 
are still under debate.3 Nevertheless, in adult patients with 
intrapulmonary airway obstruction, Rrs increases at the lower 
frequencies (characterized by Rrs0 Hz, resistance extrapolated 
to 0 Hz) and decreases when frequency increases (character-
ized by the resistance/frequency slope, Rrsslope).
Relationships between resistance 
parameters
The choice of the most clinically useful measure of airway 
resistance varies in different countries. Most North American 
clinicians use Raw0.5 (the parameter initially described 
by DuBois and colleagues),1 which primarily reflects the 
resistance in the larger central airway. Nevertheless, based on 
theoretical grounds, physical meaning can be attributed only 
to Raweff, which corresponds to a linear resistor accounting 
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for the dissipation of the nonlinear and time variant airway 
system,7 whereas the empirical measure Raw0.5 approximates 
the lowest resistance. The sRaw loop is not a simple narrow 
linear oval loop, especially in COPD patients. The area of the 
loop (taken into account in Raweff measurement)7 is related 
to the flow-resistive work of breathing, which may explain 
its correlation with activity-related dyspnea.
Our study demonstrates that among the numerical 
parameters obtained from sRaw measurements, either the 
sRawtot or sRaweff can be used interchangeably. These two 
parameters are the only ones that significantly correlate with 
activity-related dyspnea. To the best of our knowledge, this 
study is the first demonstration that specific resistance is 
one of the better descriptors of lung function due to its dual 
nature, including resistance and volume components that may 
be related to the viscoelastic behavior of the lung (kPa.s is a 
dynamic viscosity unit). In COPD patients with nonhomoge-
neous small airway partial obstruction, the sRaw loop area 
increases, especially during expiratory flow. Such alinearity 
represents expiratory flow limitation and/or dynamic airway 
compression, the former being clearly linked to activity-related 
dyspnea in COPD patients,21 which may explain our results.
We further observed that Rrs0 Hz and Rrsmean were not 
closely associated with Raw indices, except Raw0.5, which 
suggests that these measures assess more central airways. The 
Rrsslope, which has been suggested to assess more peripheral 
airways,17 was quite closely linked to Rawtot, suggesting that 
airway resistance in COPD is not as proximal as often stated4 
and that is in agreement with ex vivo measurements.22 It has 
been reported that FOT may provide useful clinical informa-
tion in COPD patients23 beyond that available from commonly 
used pulmonary function tests.17 Surprisingly, few investiga-
tors have assessed the degree of correlation between Rrs and 
Raw (with the exception of the assessment of bronchodilator 
response). The first assessment of patients with obstructive 
lung diseases using both techniques was made by Fisher, 
DuBois and Hyde.2 They showed that airway resistance rep-
resents approximately 60% of respiratory resistance, which 
also incorporates tissue resistance,2 possibly explaining the 
absence of a close relationship between Raw0.5 and Rrs.
Limitations
From our results, we cannot determine formally which 
index better assesses peripheral airways in the absence of 
a gold standard. Furthermore, since the majority of patients 
had overt airflow limitation, our study was not designed to 
evaluate the sensitivity of the indices for early disease. It 
should be noted that we described the reactive component 
of respiratory impedance only by the compliance describing 
the ability of the respiratory tract to store capacitive energy, 
primarily present in the lung periphery. One may hypothesize 
that within-breath tracking of respiratory impedance may 
give additional information.24
Assessment of activity-related dyspnea
Finally, our study showed that specific resistance and 
spirometry indices similarly but weakly explained 
  activity-related dyspnea, as assessed by the MRC score. 
The MRC score is a crude assessment of activity-related 
dyspnea, but it is the most widely used dyspnea score.25 
Since dyspnea of COPD patients results from both altered 
ventilatory   capacity (assessed by resistance or spirometry) 
and ventilatory demand (increased wasted ventilation for 
instance),26–28 the weak relationship between dyspnea and the 
indices of airway obstruction was not unexpected.
In conclusion, parameters obtained from both body 
plethysmography and forced oscillation technique can 
explore peripheral airways, and some of these parameters 
(sRawtot, sRaweff and Rrsslope) are linked to activity-related 
dyspnea in moderate to severe COPD patients.
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